About ViroCyt
ViroCyt is a company based in Denver (United States) founded in 2012 was acquired by Sartorius in July 2016.. ViroCyt has raised $8.7 million across 2 funding rounds from investors including Sartorius. ViroCyt operates in a competitive market with competitors including Quanterix, Biocare Medical, Merck, BioLife Solutions and Telesis Bio, among others.
- Headquarter Denver, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of ViroCyt
ViroCyt has successfully raised a total of $8.7M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $4 million completed in June 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $4.0M
-
First Round
First Round
(10 Apr 2013)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2015 | Amount | Series A - ViroCyt | Valuation |
investors |
|
| Apr, 2013 | Amount | Series A - ViroCyt | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ViroCyt
ViroCyt has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Sartorius. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Laboratory and biopharmaceutical equipment is developed for production processes.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ViroCyt
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ViroCyt
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Virocyt Comparisons
Competitors of ViroCyt
ViroCyt operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Quanterix, Biocare Medical, Merck, BioLife Solutions and Telesis Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Assay kits for ultra-sensitive biomarker detection are developed.
|
|
| domain | founded_year | HQ Location |
Primary antibodies and instruments for immunohistochemistry are manufactured.
|
|
| domain | founded_year | HQ Location |
Merck is engaged in science and technology solutions globally.
|
|
| domain | founded_year | HQ Location |
Tissue hypothermic storage and cryopreservation freeze media are developed.
|
|
| domain | founded_year | HQ Location |
Online platform offering life sciences reagents and kits
|
|
| domain | founded_year | HQ Location |
Portfolio of products and services for life science research and clinical diagnostic markets
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about ViroCyt
When was ViroCyt founded?
ViroCyt was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Where is ViroCyt located?
ViroCyt is headquartered in Denver, United States. It is registered at Denver, Colorado, United States.
Is ViroCyt a funded company?
ViroCyt is a funded company, having raised a total of $8.7M across 2 funding rounds to date. The company's 1st funding round was a Series A of $4.7M, raised on Apr 10, 2013.
What does ViroCyt do?
ViroCyt was founded in 2012 in Denver, United States, focusing on biotechnology tools for virus quantification. The Virus Counter 3100 is offered to measure total virus particle concentrations. Applications include vaccine production, protein expression, viral therapeutics, and anti-viral development. Operations center on providing analytical instruments for research and manufacturing in the life sciences sector.
Who are the top competitors of ViroCyt?
ViroCyt's top competitors include Biocare Medical, Merck and Siemens Healthineers.
Who are ViroCyt's investors?
ViroCyt has 1 investor. Key investors include Sartorius.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.